Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. TapImmune
TPIV

Buy TapImmune (TPIV) Stock

TPIV
See TPIV stock price and Buy/Sell TapImmune with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
TPIV

TapImmune (TPIV)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About TapImmune (TPIV)

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Market Cap
$29.62M
1 Year High
$2.05
Volume
1 Year Low
$0.25
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch TPIV stock

TapImmune stock rating

What analysts recommend for TPIV stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell

TapImmune price target

What analysts think TPIV will be worth
Low $0
High $2.05
Current $0
Target $0

Buy TapImmune (TPIV) Stock

TPIV
See TPIV stock price and Buy/Sell TapImmune with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch TPIV stock
  • Nfrazier97 avatar
  • melielyxxx avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.